Chroma Medicine
WEBBuilding on groundbreaking research from the world’s foremost genomic medicine experts, Chroma is developing an entirely new class of therapeutics to achieve unparalleled control of gene expression—all without cutting, nicking, or altering the DNA sequence.
Chroma Medicine Secures $135M in Series B Financing to …
WEBMar 1, 2023 · Funding to progress Chroma's single-dose epigenetic editing therapies and support expansion of novel genetic medicine platform designed to enable precise gene regulation while preserving...
News - Chroma Medicine
WEBRead the latest news and media about Chroma and our epigenetic editing approach to treating genetically driven disease.
News & Press Releases - Chroma Technology Corp
WEBApr 2024. Chroma Technology named one of the Best Places to Work in Vermont for 2024. Chroma Technology is honored to be named a Best Place to Work in Vermont for the 7th year by VermontBiz and the Vermont Chamber of Commerce… Feb 2024. Chroma Technology Wraps Up 3rd Annual 2:1 Match Program.
Chroma Medicine Presents Preclinical In Vivo Data Showing …
WEBNov 11, 2023 · Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today presented new preclinical data demonstrating that a single administration...
Chroma Medicine Launches with $125M in Financing to Deliver …
WEBCAMBRIDGE, Mass., Nov. 17, 2021 /PRNewswire/ -- Chroma Medicine, Inc., (Chroma) a new genomic medicine company pioneering epigenetic editing, launched today with $125M in financing. Atlas...
Chroma Medicine Launches with $125M in Financing to Deliver …
WEBCAMBRIDGE, Mass., Nov. 17, 2021 /PRNewswire/ -- Chroma Medicine, Inc., (Chroma) a new genomic medicine company pioneering epigenetic editing, launched today with $125M in financing. Atlas...
Chroma Medicine Presents Preclinical In Vivo Data Showing …
WEBNov 11, 2023, 10:00 ET. Share this article. This first presentation of non-human primate (NHP) data highlights the potential of Chroma's epigenetic editors to achieve specific and robust...
Chroma Medicine Presents Data Showing Specific and Durable …
WEBSep 20, 2023 · Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today presented positive preclinical data demonstrating the potential of its...
Chroma Medicine and Tune Therapeutics: Two companies take up …
WEBSep 5, 2022 · Chroma Medicine and Tune Therapeutics: Two companies take up epigenome editing Defanged CRISPR systems hooked up to enzymatic domains may bring epigenome therapies to precision medicine....
Skip to content